myelogenous leukemia Clinical Research Trials

Please select a valid location from the dropdown

Filter By

Clear all Advanced

Advanced Filters

Gender
Phase
Study Type
Sponsors
Accepts healthy volunteers
Online Trials
Age Group

Female only (1)
Any (20)

Phase 1 (3)
Phase 1/2 (2)
Phase 2 (6)
Phase 2/3 (1)
Phase 3 (2)
Unknown (7)

Interventional (14)
Observational (6)

Children's Oncology Group (2)
Roswell Park Cancer Institute (2)
AbbVie (1)
Astex Pharmaceuticals, Inc. (1)
Baylor College of Medicine (1)
BioTheryX, Inc. (1)
Chongqing Precision Biotech Co., Ltd (1)
City of Hope Medical Center (1)
Helsinki University Central Hospital (1)
M.D. Anderson Cancer Center (1)
Medical University of Vienna (1)
PETHEMA Foundation (1)
Shanghai Jiao Tong University School of Medicine (1)
The University of Hong Kong (1)
University of Birmingham (1)
University of Washington (1)
Washington University School of Medicine (1)
Zhejiang University (1)

No (20)
Yes (1)

No (21)

Adult (18+) (21)
Pediatric (Under 18) (8)

I am/have/had

I am/have/hadejection fraction

I am/have/hadcellular therapy

I am/have/hadacute promyelocytic leukemia

I am/have/hadcomplete blood count

I am/have/hadmyelodysplastic syndromes

I am/have/hadchronic myelomonocytic leukemia (cmml)

I am/have/hadmyelodysplastic/myeloproliferative disease

I am/have/hadHIV Infection

I am/have/hadblast count

I am/have/hadchronic phase chronic myeloid leukemia

I am/have/hadclag regimen

I am/have/hadblast crisis

I am/have/hadmyelodysplasia

I am/have/hadBRAF

I am/have/hadbone marrow core biopsy

I am/have/hadfibrosis

I am/have/hadantibody response

I am/have/hadrenal function

I am/have/hadrenal function test

I am/have/hadacute myeloid leukemia

added new label for I am/have/had

I am looking for

I am looking foranagrelide

I am looking foridarubicin

I am looking forhuman chorionic gonadotropin (hcg)

I am looking forcedazuridine

I am looking forg-csf

I am looking forgrowth factor

I am looking forfedratinib

I am looking forfludarabine

I am looking fortrametinib

I am looking forhepatitis b

I am looking fortacrolimus

I am looking foranthracyclines

I am looking formethotrexate

I am looking forvincristine

I am looking forimmunosuppressive agents

I am looking forbosutinib

I am looking forgilteritinib

I am looking forpediatric

I am looking forgranulocyte colony stimulating factor

I am looking fordecitabine

added new label for I am looking for

Advanced Filters

Found 497 clinical trials

None

None views

For Seniors
For adults
Recruiting in 10s
Interventional Study
all
Hematology
Recruiting

Decitabine+Cladribine+Cytarabine+Granulocyte Colony-stimulating Factor (D-CLAG) for Relapsed or Refractory Acute Myeloid Leukemia (AML)

A prospective, single-arm, multicenter, exploratory study to evaluate the efficacy and safety of D-CLAG regimen in the treatment of relapsed or refractory acute myeloid leukemia

idarubicin

ejection fraction

acute promyelocytic leukemia

clag regimen

myeloid leukemia

0 views
19 Feb, 2024

Phase 1
For pediatric ages
For Seniors
Recruiting in 10s
Interventional Study
all
Hematology
Recruiting

Chimeric Antigen Receptor T-cells for The Treatment of AML Expressing CLL-1 Antigen

Patients eligible for this study have a type of blood cancer Acute Myeloid Leukemia (AML) which has come back or has not gone away after treatment. The body has different ways of fighting disease and infection, and this research study combines two different ways of fighting cancer with antibodies and …

allogeneic hematopoietic stem cell transplant

hematologic malignancy

leukemia

aptt

pulse oximetry

0 views
19 Feb, 2024

Phase 2
For Seniors
For adults
Recruiting in 100s
Interventional Study
all
Hematology
Recruiting

Study of Venetoclax in Combination With Azacytidine in AML Patients Selected Using Ex Vivo Drug Sensitivity Screening

This is a multi center two-stage, two-arm, open label phase II study of venetoclax in combination with azacytidine in acute myeloid leukemia patients selected for therapy with ex vivo venetoclax sensitivity screening. This study will characterize the usability of ex vivo drug sensitivity testing for patient selection for selecting the …

ejection fraction

acute promyelocytic leukemia

induction chemotherapy

secondary acute myeloid leukemia

HIV Infection

0 views
19 Feb, 2024